Exercise may supercharge immunotherapy in lung cancer patients

NCT ID NCT06983899

Recruiting now Symptom relief Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times

Summary

This study tests whether adding aerobic interval training (short bursts of intense exercise with rest periods) can improve immune activity and treatment response in 100 adults with non-small cell lung cancer who are already receiving immunotherapy. The goal is to see if exercise helps the body fight cancer more effectively and reduces treatment resistance. Participants must be at least 18, have a confirmed diagnosis, and plan to continue immunotherapy for at least 24 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fred Hutch/University of Washington Cancer Consortium
RECRUITING

Seattle, Washington, 98109, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

LUNG NON-SMALL CELL CARCINOMA